c-Met is a new prognostic biomarker in glioblastoma patients

被引：0
|
作者：
Petterson, Stine A. [1 ,2 ]
Hermansen, Simon K. [1 ,2 ]
Dahlrot, Rikke H. [1 ,2 ,3 ]
Hansen, Steinbjorn [2 ,3 ]
Kristensen, Bjarne W. [1 ,2 ]
机构：
[1] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark
[2] Univ Southern Denmark, Inst Clin Res, Odense, Denmark
[3] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
来源：
APMIS | 2014年 / 122卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [41] Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
    Zhao, Xixi
    Qu, Jingkun
    Hui, Yuxin
    Zhang, Hong
    Sun, Yuchen
    Liu, Xu
    Zhao, Xiaoyao
    Zhao, Zitong
    Yang, Qian
    Wang, Feidi
    Zhang, Shuqun
    ONCOTARGET, 2017, 8 (34) : 56758 - 56767
  • [42] The Prognostic Significance of C-Met and EGFR Overexpression in Gastric Carcinomas
    Paliga, A.
    Marginean, H.
    Purgina, B.
    Tessier, B.
    Jonker, D.
    Marginean, E. C.
    MODERN PATHOLOGY, 2014, 27 : 196A - 196A
  • [43] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [44] c-Met: A new target for nanoparticle therapeutics
    Harris, Alesha
    Phelps, Amanda
    Petros, Robby A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [45] The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with Radical Chemo-Radiotherapy
    Houssiau, Helene
    Pairet, Geraldine
    Dano, Helene
    Seront, Emmanuel
    CURRENT ONCOLOGY, 2023, 30 (12) : 10550 - 10555
  • [46] Expression and prognostic value of c-met in canine mammary tumours
    Chen, Yi-Chen
    Chen, Ying-Yu
    Liao, Jiunn-Wang
    Chang, Shih-Chieh
    VETERINARY AND COMPARATIVE ONCOLOGY, 2018, 16 (04) : 670 - 676
  • [47] The Prognostic Significance of C-Met and EGFR Overexpression in Gastric Carcinomas
    Paliga, A.
    Marginean, H.
    Purgina, B.
    Tessier, B.
    Jonker, D.
    Marginean, E. C.
    LABORATORY INVESTIGATION, 2014, 94 : 196A - 196A
  • [48] c-Met ectodomain shedding as a potential tumor biomarker in vivo.
    Giubellino, A
    Dharmawardana, PG
    Coleman, JA
    Sun, JL
    Burgess, TL
    Bottaro, DP
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9065S - 9065S
  • [49] The utility of c-Met as a diagnostic tissue biomarker in primary colorectal cancer
    Armstrong, Gemma R.
    Khot, Mohammed Ibrahim
    Tiernan, Jim P.
    West, Nick P.
    Perry, Sarah L.
    Maisey, Tom, I
    Hughes, Thomas A.
    Jayne, David G.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2021, 102 (03) : 172 - 178
  • [50] Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma
    Papa, Eleanna
    Weller, Michael
    Weiss, Tobias
    Ventura, Elisa
    Burghardt, Isabel
    Szabo, Emese
    CELL DEATH & DISEASE, 2017, 8
12345